FTC Review of Pharmacy Chain Consolidation

Retail pharmacies fill most short-term prescriptions and give vaccines and basic care. Three national chains operate thousands of US locations, increasingly alongside mail-order and specialty pharmacies.

Rite Aid's bankruptcy removed a competitor in many towns. When assets sell, the buyer may be a rival chain or a private equity group—each scenario raises different competition questions.

CVS vertically integrates Caremark (PBM) and Aetna (insurance). Critics say that stack steers patients to CVS stores and squeezes independents on reimbursement.

Walgreens faced shareholder pressure and announced closures, citing theft and reimbursement rates. Communities labeled some areas 'pharmacy deserts' when the last chain left.

The FTC connects pharmacy consolidation to its PBM study: if middlemen pay stores below cost, chains exit even when customers need local access.

States sued or legislated on clinic closures independently while federal enforcers evaluate mergers crossing HSR thresholds.

Ongoing reviews mean describing harm as a live concern, not a completed finding that every chain closure violated antitrust law.

Losing the last pharmacy in town affects seniors and rural families most.

Insurance-PBM-pharmacy vertical stacks mirror tech platform self-preferencing.

Merger reviews on bankrupt chains can lock in local monopolies for decades.

Specialty drug access may concentrate in mail-order arms tied to PBMs.

Store acquisitions may substantially lessen pharmacy competition locally.

Vertical integration encourages steering and discriminatory reimbursement.

Coordinated closures reduce choice even without a formal merger.

Private equity roll-ups may strip assets and raise prices post-sale.

Chains cite low generic reimbursement and crime as closure drivers.

They argue mail-order improves convenience for maintenance drugs.

Buyers of bankrupt stores say they preserve jobs and access.

They maintain local markets still include grocers and independents.

If your pharmacy closes, ask insurers about in-network alternatives before auto-enrollment in mail-order.

Independent pharmacies may negotiate outside PBM-owned networks—compare cash prices.

Comment on local merger reviews when FTC or state AGs seek public input.

Until orders issue, chains may continue closing under business judgment.